Form 4: Jazz Pharma Director Transfers Shares in Marital Asset Division

Jazz Pharmaceuticals plc Director Patrick G. Enright transferred 5,000 ordinary shares to a former spouse as part of a marital asset division.

Summary

• Patrick G. Enright, a Director of Jazz Pharmaceuticals plc, reported a change in beneficial ownership.
• On August 18, 2025, Mr. Enright disposed of 5,000 ordinary shares.
• The shares were transferred to his former spouse without consideration as part of a comprehensive division of marital assets.
• Following this transaction, Mr. Enright's direct beneficial ownership stands at 21,379 ordinary shares.

Sentiment

Score: 5

Explanation: Neutral. This filing reports a personal transaction of a director and has no direct bearing on the company's operational or financial performance. The decrease in director ownership is noted but is due to a personal legal matter.

Positives

• This filing is purely a personal transaction for a director and does not reflect on the company's operational or financial performance.

Negatives

• The director's beneficial ownership in the company has decreased by 5,000 shares.

Future Outlook

No forward-looking statements regarding Jazz Pharmaceuticals plc's operational or financial performance are provided in this filing.

Management Comments

• Shares transferred to former spouse without consideration as part of a comprehensive division of marital assets. Following the transfer, the reporting person no longer has beneficial ownership of the transferred shares.

Industry Context

This is a personal transaction by a director and does not provide insight into broader industry trends or the competitive landscape for Jazz Pharmaceuticals plc.

Legal Proceedings

• The transaction is a result of a 'comprehensive division of marital assets,' indicating a personal legal proceeding for the director, not a corporate legal matter.

Stakeholder Impact

• Shareholders: A minor decrease in director ownership, but unlikely to have a material impact on the company's stock price or operations.
• Employees, Customers, Suppliers, Creditors: No direct impact.

Key Dates

Keywords

Jazz Pharmaceuticals, JAZZ, Form 4, Insider Transaction, Director Share Transfer, Beneficial Ownership, Patrick Enright, Marital Asset Division